MYC and cancer: While this has greatly limited their therapeutic utility in cancer treatment, where sustained and complete Myc inhibition is sought, our data indicate that even the partial and episodic inhibition of Myc afforded by such indirect agents might yet prove effective for cancer prophylaxis and that a tolerable regimen might perhaps be found that balances prophylactic efficacy with minimal side effects.